[1] Ludmer PL,Selwyn AP,Shook TL,et al.Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries[J].N Engl J Med,1986,315 (17):1046-1051. [2] Matsumoto T,Yoshiyama S,Wakabayashi K,et al.Ef-fects of chronic insulin on endothelial dysfunction of basi-lar arteries from established streptozotocin-diabetic rats[J].Eur J Pharmacol,2004,504(12):119-127. [3] Panza JA ,Garcia CE,Kilcoyne CM,et al.Impaired endothelium-dependent vasodilation in patients with essential hypertension.Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway[J].Cir-culation,1995,91(6):1732-1738. [4] Fenster BE,Tsao PS,Rockson SG.Endothelial dysfunc-tion:Clinical strategies for treating oxidant stress[J].Am Heart J,2003,146(2):218-226. [5] Selvendiran K,Koga H,Ueno T,et al.Luteolin promotes degradation in signal transducer and activator of transcrip-tion 3 in human hepatoma cells :an implication for the an-titumor potential of flavonoids[J].Cancer Res,2006,66(9):4826-4834. [6] Qiusheng Z,Yuntao Z,Rongliang Z,et al.Effects of verbascoside and luteolin on oxidative damage in brain of heroin treated mice[J].Pharmazie,2005,60(7):539-543. [7] Li Z,Zhou Y,Zhang N,et al.Evaluation of the anti-in-flammatory activity of luteolin in experimental models[J]. Planta Med,2007,73(3):221-226. [8] Wang L,Han C,Wan P.Experiment research on luteolin affecting coronary circulation dynamics[J].Chin Pharma-col Bull,1992,8(5):388-390. [9] Calderone V,Chericoni S,Martinelli C,et al.Vasorelax-ing effects of flavonoids:investigation on the possible in-volvement of potassium channels[J].Naunyn Schmiede-bergs Arch Pharmacol,2004,370(4):290-298. [10] Chan EC,Pannangpetch P,Woodman OL.Relaxation to flavones and flavonols in rat isolated thoracic aorta:mech-anism of action and structure-activity relationships[J].J Cardiovasc Pharmacol,2000,35(2):326-333. [11] Heymes C,Habib A ,Yang D,et al.Cyclo-oxygenase-1 and-2 contribution to endothelial dysfunction in ageing[J].Br J Pharmacol,2000,131(4):804-810. [12] Schilling WP,Elliott SJ.Ca2+ signaling mechanisms of vascular endothelial cells and their role in oxidant-induced endothelial cell dysfunction[J].Am J Physiol,1992,262(6):H1617-H1630. [13] Elliott SJ,Schilling WP.Oxidant stress alters Na + pump and Na+-K+-Cl--cotransporter activities in vascular en-dothelial cells[J].Am J Physiol,1992,263(1 Pt 2):H96-H102. [14] Gurtner GH,Burke-Wolin T.Interactions of oxidant stress and vascular reactivity[J].Am J Phy siol,1991,260 (4Pt1)L207-L211. [15] Garcia-Cohen EC,Marin J,Diez-Picazo LD,et al.Oxi-dative stress induced by ter t-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats:role of cyclooxygenase-2 isoform[J].J Pharmacol Exp Ther,2000,293(1):75-81. [16] Harrison DG,Ohara Y.Physiologic consequences of in-creased vascular oxidant stresses in hypercholesterolemia and atherosclerosis :implications for impaired vasomotion[J].Am J Cardiol,1995,75(6):75B-81B. [17] Witting PK,Rayner BS,Wu BJ,et al.Hydrogen perox-ide promotes endothelial dysfunction by stimulating multiple sources of superoxide anion radical production and de-creasing nitric oxide bioavailability[J].Cell Physiol Bio-chem,2007,20(5):255-268. [18] Boulden BM,Widder JD,Allen JC,et al.Early Determi-nants of H2O2-Induced Endothelial Dy sfunction[J].Free Radic Biol Med,2006,41(5):810-817. |